World - Other Medicaments For Therapeutic Or Prophylactic Uses - Market Analysis, Forecast, Size, Trends And Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingOther medicaments for therapeutic or prophylactic uses market
Other medicaments for therapeutic or prophylactic uses market: get access to new datasets secured by an Ai-driven BI tool. Info contain market size, companies, exports, consumption, market prices, trade, production, and imports. Here is a breakdown by country, including the U.K., Russia, Latin America, the Middle East, EU, Africa, China, and the U.S. Market insights and forecast to 2030 are also featured in the reports.
Other Medicaments for Therapeutic or Prophylactic Uses - World's Largest Markets
| Rating | Country |
|---|---|
| 1 | Japan |
| 2 | Russia |
| 3 | China |
| 4 | United States |
| 5 | India |
In value terms, Japan, Russia and China were the countries with the highest levels of market value in 2020, together comprising 61% of the global market.
Russia saw the highest growth rate of market size, in terms of the main consuming countries over the period under review, while market of other medicaments for therapeutic or prophylactic uses for the other global leaders experienced more modest paces of growth.
Other Medicaments For Therapeutic Or Prophylactic Uses Prices
Lowest Prices - FOB - Top Exporters
| COUNTRY | 2018 | 2019 | 2020 | CAGR, 2018-2020 |
|---|---|---|---|---|
| USD per ton | ||||
| Canada | 4371 | 4454 | 4371 | 0.0% |
| China | 16026 | 15139 | 13473 | -8.3% |
| India | 19211 | 19670 | 17145 | -5.5% |
| Jordan | 24500 | 25039 | 18318 | -13.5% |
| United Kingdom | 42432 | 25160 | 23191 | -26.1% |
| United States | 47622 | 34054 | 35872 | -13.2% |
| Spain | 24904 | 16030 | 39688 | 26.2% |
| France | 44704 | 53044 | 46478 | 2.0% |
| Italy | 75345 | 62700 | 52110 | -16.8% |
| Belgium | 86199 | 65498 | 57214 | -18.5% |
| Netherlands | 79197 | 79187 | 83023 | 2.4% |
| Germany | 211953 | 138342 | 166356 | -11.4% |
| Switzerland | 159951 | 254838 | 180297 | 6.2% |
| Average | 51087 | 42277 | 46653 | -4.4% |
Prices varied noticeably by the country of origin; the country with the highest price was Switzerland ($180,297 per ton), while Canada ($4,371 per ton) was amongst the lowest.
From 2018 to 2020, the most notable rate of growth in terms of prices was attained by Spain, while the other global leaders experienced more modest paces of growth.
Highest Prices - CIF - Top Importers
| COUNTRY | 2018 | 2019 | 2020 | CAGR, 2018-2020 |
|---|---|---|---|---|
| USD per ton | ||||
| United Kingdom | 108709 | 164478 | 152190 | 18.3% |
| Ireland | 121896 | 97806 | 106846 | -6.4% |
| Germany | 55601 | 48467 | 72222 | 14.0% |
| Netherlands | 53990 | 43553 | 71952 | 15.4% |
| Spain | 33681 | 25041 | 61571 | 35.2% |
| China | 43004 | 45500 | 29210 | -17.6% |
| Brazil | 18609 | 16475 | 24012 | 13.6% |
| Mexico | 23246 | 43690 | 22546 | -1.5% |
| Thailand | 15634 | 17182 | 18794 | 9.6% |
| United States | 53757 | 22889 | 16131 | -45.2% |
| Poland | 6541 | 6676 | 7353 | 6.0% |
| France | 8587 | 8702 | 6283 | -14.5% |
| Average | 48923 | 51427 | 53793 | 4.9% |
Prices varied noticeably by the country of destination; the country with the highest price was the UK ($152,190 per ton), while France ($6,283 per ton) was amongst the lowest.
From 2018 to 2020, the most notable rate of growth in terms of prices was attained by Spain, while the other global leaders experienced more modest paces of growth.
Other Medicaments for Therapeutic or Prophylactic Uses - Top Importers
| COUNTRY | 2018 | 2019 | 2020 | CAGR, 2018-2020 |
|---|---|---|---|---|
| billion USD | ||||
| Netherlands | 0.3 | 0.2 | 3.4 | 213.2% |
| United Kingdom | 3.2 | 4 | 3.2 | 1.3% |
| Ireland | 1.3 | 1.1 | 1.1 | -9.3% |
| Spain | 0.3 | 0.2 | 0.5 | 29.9% |
| Germany | 0.8 | 0.7 | 0.5 | -21.5% |
In value terms, the largest other medicaments for therapeutic or prophylactic uses importing markets worldwide were the Netherlands ($3.4B), the UK ($3.2B) and Ireland ($1.1B), together comprising 63% of global imports.
Among the main importing countries, the Netherlands (+213.2% per year) recorded the highest growth rate of the value of imports, over the period under review, while purchases for the other global leaders experienced more modest paces of growth.
Other Medicaments for Therapeutic or Prophylactic Uses - Top Exporters
| COUNTRY | 2018 | 2019 | 2020 | CAGR, 2018-2020 |
|---|---|---|---|---|
| billion USD | ||||
| Netherlands | 0.4 | 0.7 | 3.1 | 173.9% |
| United States | 1.1 | 1.1 | 1.2 | 3.6% |
| Switzerland | 0.3 | 0.2 | 0.7 | 56.1% |
| Germany | 1.1 | 0.6 | 0.7 | -22.1% |
| Spain | 0.08 | 0.07 | 0.6 | 171.3% |
In value terms, the Netherlands ($3.1B) emerged as the largest other medicaments for therapeutic or prophylactic uses supplier worldwide, comprising 31% of global exports. The second position in the ranking was occupied by the United States ($1.2B), with a 12% share of global exports. It was followed by Switzerland, with a 7.2% share.
From 2018 to 2020, the average annual growth rate of value in the Netherlands amounted to +173.9%. In the other countries, the average annual rates were as follows: the United States (+3.6% per year) and Switzerland (+56.1% per year).
Other Medicaments for Therapeutic or Prophylactic Uses - Market Forecast
Driven by increasing demand for other medicaments for therapeutic or prophylactic uses worldwide, the market is expected to continue an upward consumption trend over the next decade. Market performance is forecast to decelerate, expanding with an anticipated CAGR of for the period from 2020 to 2030, which is projected to bring the market volume to by the end of 2030.
Other Medicaments for Therapeutic or Prophylactic Uses - Product Coverage
- HS 300390 - Medicaments; (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale)
- Prodcom 21201320 - Other medicaments for therapeutic or prophylactic uses, of HS
This report provides an in-depth analysis of the global market for other medicaments for therapeutic or prophylactic uses. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201320 - Other medicaments for therapeutic or prophylactic uses, of HS
Country coverage:
Worldwide - the report contains statistical data for 200 countries and includes detailed profiles of the 50 largest consuming countries:
- USA
- China
- Japan
- Germany
- United Kingdom
- France
- Brazil
- Italy
- Russian Federation
- India
- Canada
- Australia
- Republic of Korea
- Spain
- Mexico
- Indonesia
- Netherlands
- Turkey
- Saudi Arabia
- Switzerland
- Sweden
- Nigeria
- Poland
- Belgium
- Argentina
- Norway
- Austria
- Thailand
- United Arab Emirates
- Colombia
- Denmark
- South Africa
- Malaysia
- Israel
- Singapore
- Egypt
- Philippines
- Finland
- Chile
- Ireland
- Pakistan
- Greece
- Portugal
- Kazakhstan
- Algeria
- Czech Republic
- Qatar
- Peru
- Romania
- Vietnam
+ the largest producing countries
Data coverage:
- Global market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Global production, split by region and country
- Global trade (exports and imports)
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- CONSUMPTION BY COUNTRY
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. GLOBAL PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
- PRODUCTION BY COUNTRY
8. GLOBAL IMPORTS
The Largest Importers on The Market and How They Succeed
- IMPORTS FROM 2012–2024
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. GLOBAL EXPORTS
The Largest Exporters on The Market and How They Succeed
- EXPORTS FROM 2012–2024
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
11. COUNTRY PROFILES
The Largest Markets And Their Profiles
This Chapter is Available Only for the Professional Edition PRO- United States
- China
- Japan
- Germany
- United Kingdom
- France
- Brazil
- Italy
- Russian Federation
- India
- Canada
- Australia
- Republic of Korea
- Spain
- Mexico
- Indonesia
- Netherlands
- Turkey
- Saudi Arabia
- Switzerland
- Sweden
- Nigeria
- Poland
- Belgium
- Argentina
- Norway
- Austria
- Thailand
- United Arab Emirates
- Colombia
- Denmark
- South Africa
- Malaysia
- Israel
- Singapore
- Egypt
- Philippines
- Finland
- Chile
- Ireland
- Pakistan
- Greece
- Portugal
- Kazakhstan
- Algeria
- Czech Republic
- Qatar
- Peru
- Romania
- Vietnam
-
LIST OF TABLES
- Key Findings In 2024
- Market Volume, In Physical Terms, 2012–2024
- Market Value, 2012–2024
- Per Capita Consumption, By Country, 2018–2024
- Production, In Physical Terms, By Country, 2012–2024
- Imports, In Physical Terms, By Country, 2012–2024
- Imports, In Value Terms, By Country, 2012–2024
- Import Prices, By Country Of Destination, 2012–2024
- Exports, In Physical Terms, By Country, 2012–2024
- Exports, In Value Terms, By Country, 2012–2024
- Export Prices, By Country Of Origin, 2012–2024
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2024
- Market Value, 2012–2024
- Consumption, By Country, 2024
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2024
- Production, In Value Terms, 2012–2024
- Production, By Country, 2024
- Production, In Physical Terms, By Country, 2012–2024
- Imports, In Physical Terms, 2012–2024
- Imports, In Value Terms, 2012–2024
- Imports, In Physical Terms, By Country, 2024
- Imports, In Physical Terms, By Country, 2012–2024
- Imports, In Value Terms, By Country, 2012–2024
- Import Prices, By Country, 2012–2024
- Exports, In Physical Terms, 2012–2024
- Exports, In Value Terms, 2012–2024
- Exports, In Physical Terms, By Country, 2024
- Exports, In Physical Terms, By Country, 2012–2024
- Exports, In Value Terms, By Country, 2012–2024
- Export Prices, 2012–2024
225
This report provides an in-depth analysis of the global market for other medicaments for therapeutic or prophylactic uses.
302
This report provides an in-depth analysis of the global market for medicaments of alkaloids or derivatives thereof.
178
This report provides an in-depth analysis of the global market for medicaments of other antibiotics.
353
This report provides an in-depth analysis of the global medicaments containing hormones market.
362
This report provides an in-depth analysis of the global medicaments containing insulin market.
442
This report provides an in-depth analysis of the global medicaments containing penicillin market.
265
Explore the top 10 import markets for non-antibiotic, non-hormone, non-alkaloid medicaments based on the latest data. Discover the key countries driving the demand for therapeutic and prophylactic medicaments.
186
Discover the top countries by import value of non-penicillin or streptomycin antibiotic medicaments in 2023. Explore key statistics and market insights.
125
Discover the top import markets for medicaments containing hormones, including Belgium, Denmark, United States, and more. Learn about the key players in the global market for hormone medications.
225
Pharmaceutical companies are fiercely competing in the obesity drug market, with Eli Lilly and Novo Nordisk among the major players. Innovations and collaborations are key in this dynamic and lucrative sector.
174
Novo Holdings finalizes $16.5 billion acquisition of Catalent, enhancing pharmaceutical capabilities amidst regulatory clearance.
